Literature DB >> 4626307

Toxicity of L-asparginase in children with advanced leukemia.

V J Land, W W Sutow, D J Fernbach, D M Lane, T E Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4626307     DOI： 10.1002/1097-0142(197208)30:2<339::aid-cncr2820300206>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  22 in total

1.  Side effects of colaspase.

Authors:  G Summerfield; D Swirsky
Journal:  Br Med J       Date:  1978-11-11

2.  Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Authors:  Joanne Kurtzberg; Barbara Asselin; Mark Bernstein; George R Buchanan; Brad H Pollock; Bruce M Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2011-12       Impact factor: 1.289

Review 3.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

4.  Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.

Authors:  S-H Chen; D Pei; W Yang; C Cheng; S Jeha; N J Cox; W E Evans; C-H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2010-06-30       Impact factor: 6.875

5.  Understanding the Profile of Cancer-Related Cognitive Impairments: A Critique of Meta-Analyses.

Authors:  Todd S Horowitz; Melissa Treviño; Ingrid M Gooch; Korrina A Duffy
Journal:  J Natl Cancer Inst       Date:  2019-10-01       Impact factor: 13.506

6.  Myelosuppressive effect of colaspase (L-asparaginase) in initial treatment of acute lymphoblastic leukaemia.

Authors:  P G Johnston; R M Hardisty; H E Kay; P G Smith
Journal:  Br Med J       Date:  1974-07-13

7.  A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma.

Authors:  H B Muss; N Spell; D Scudiery; R L Capizzi; M R Cooper; J Cruz; D V Jackson; F Richards; C L Spurr; D R White
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

8.  The effect of E. coli L-asparaginase on oral glucose tolerance and insulin release in man.

Authors:  R L Lavine; I Brodsky; C D Garofano; L I Rose
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

Review 9.  Drug-induced pancreatitis.

Authors:  T Wilmink; T W Frick
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

10.  Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.

Authors:  Susan L Kearney; Suzanne E Dahlberg; Donna E Levy; Stephan D Voss; Stephen E Sallan; Lewis B Silverman
Journal:  Pediatr Blood Cancer       Date:  2009-08       Impact factor: 3.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.